Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2025-11-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.8bn
reported value
+33.1% vs Q2 2025
33positions
69.0%in top 10
2 new
6 added
6 reduced
0 sold out
vs Q2 2025
Holdings, Q3 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $337.4m18.99% | Unchanged |
| METSERA INC COM | $196.3m11.05% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $153.9m8.66% | Added +399.0k |
| CIDARA THERAPEUTICS INC CDTX | $90.7m5.10% | Added +307.7k |
| VIRIDIAN THERAPEUTICS INC VRDN | $83.8m4.72% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $82.0m4.61% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $79.8m4.49% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $79.2m4.46% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $66.0m3.72% | Reduced -800.0k |
| COGENT BIOSCIENCES INC COGT | $57.4m3.23% | Reduced -755.4k |
| CYTOMX THERAPEUTICS INC CTMX | $49.6m2.79% | Added +1.6m |
| ABIVAX SA ABVX | $49.0m2.76% | Reduced -769.1k |
| SAVARA INC SVRA | $45.3m2.55% | Added +3.8m |
| SPYRE THERAPEUTICS INC SYRE | $45.0m2.53% | Unchanged |
| ERASCA INC ERAS | $38.9m2.19% | Unchanged |
| DIANTHUS THERAPEUTICS INC DNTH | $37.8m2.13% | Reduced -39.2k |
| ENGENE HOLDINGS INC COM | $34.5m1.94% | Unchanged |
| MAZE THERAPEUTICS INC MAZE | $31.9m1.80% | New |
| JADE BIOSCIENCES INC JBIO | $27.8m1.56% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $27.5m1.55% | Unchanged |
| VOR BIOPHARMA INC VOR | $24.4m1.37% | New |
| UPSTREAM BIO INC UPB | $22.0m1.24% | Reduced -1.1m |
| ZURA BIO LTD ZURA | $20.1m1.13% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $17.9m1.01% | Unchanged |
| PHARVARIS N V PHVS | $16.8m0.95% | Reduced -1.4m |
| CRESCENT BIOPHARMA INC. CBIO | $16.5m0.93% | Unchanged |
| SEPTERNA INC SEPN | $11.5m0.65% | Added +70.4k |
| CULLINAN THERAPEUTICS INC CGEM | $8.2m0.46% | Unchanged |
| SURROZEN INC SRZN | $8.2m0.46% | Unchanged |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $8.0m0.45% | Unchanged |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $4.6m0.26% | Unchanged |
| TENAX THERAPEUTICS INC TENX | $3.3m0.19% | Added +339.1k |
| CASI PHARMACEUTICALS INC CASIF | $1.6m0.09% | Unchanged |